Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer.

Aminkeng, Folefac; Ross, Colin J D; Rassekh, Shahrad R; Rieder, Michael J; Bhavsar, Amit P; Sanatani, Shubhayan; Bernstein, Daniel; Hayden, Michael R; Amstutz, Ursula; Carleton, Bruce C (2017). Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer. British journal of clinical pharmacology, 83(5), pp. 1143-1145. Wiley-Blackwell 10.1111/bcp.13218

[img] Text
Aminkeng_et_al-2017-British_Journal_of_Clinical_Pharmacology.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (172kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry

UniBE Contributor:

Amstutz, Ursula

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0306-5251

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Ursula Amstutz

Date Deposited:

19 Feb 2018 15:35

Last Modified:

19 Feb 2018 15:44

Publisher DOI:

10.1111/bcp.13218

PubMed ID:

28317142

Uncontrolled Keywords:

anthracycline anthracycline-induced cardiotoxicity cancer chemotherapy clinical practice guidelines congestive heart failure pharmacogenomic screening

BORIS DOI:

10.7892/boris.108841

URI:

https://boris.unibe.ch/id/eprint/108841

Actions (login required)

Edit item Edit item
Provide Feedback